Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04982419 · ClinicalTrials.gov registry record · Phase 2
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
A Phase 2 study of Heart Failure and Acute Kidney Injury, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 3
- Study locations
NCT04982419 is a Phase 2 study of Heart Failure and Acute Kidney Injury that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 240 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04982419, a Phase 2 study of Heart Failure and Acute Kidney Injury, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.
Conditions Studied
Interventions
- DEVICE Remote ischemic preconditioning
- DEVICE Sham remote ischemic conditioning
Study Locations (3)
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Virginia
- Hunter Holmes McGuire VA Medical Center, Richmond, VA - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2029-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04982419
The ClinicalTrials.gov registry entry for NCT04982419 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (88% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Remote ischemic preconditioning is the first listed.
NCT04982419 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT04982419 about?
NCT04982419 is a clinical study titled "Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial". This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure underg...
What is the current status of trial NCT04982419?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2021-11-01. Estimated completion is 2029-03-31.
What conditions does trial NCT04982419 study?
This clinical trial studies the following conditions: Heart Failure, Acute Kidney Injury, Percutaneous Coronary Intervention, Contrast Induced Nephropathy, Coronary Angiography.
What interventions are being tested in trial NCT04982419?
The interventions under investigation include: Remote ischemic preconditioning (DEVICE), Sham remote ischemic conditioning (DEVICE).
Who is sponsoring clinical trial NCT04982419?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04982419 being conducted?
This trial has 3 study locations across Pennsylvania, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
RECRUITING · Phase 2
-
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
RECRUITING · Phase 2
-
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · Phase 2
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
-
Metformin for Pulmonary Hypertension HFpEF
RECRUITING · Phase 2
-
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.